<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390997</url>
  </required_header>
  <id_info>
    <org_study_id>2019-TDU-DÄ°SF-0009</org_study_id>
    <nct_id>NCT04390997</nct_id>
  </id_info>
  <brief_title>Determination of the Levels of Lipocalin-2 and Semaphorin3A</brief_title>
  <official_title>Determination of the Levels of Lipocalin-2 and Semaphorin3A in Gingival Crevicular Fluid in Subjects With Different Periodontal Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Izmir Katip Celebi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Izmir Katip Celebi University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical trial is to investigate the concentrations of Lipocalin-2 and
      Semaphorin 3A levels in gingival crevicular fluid in subjects with different periodontal
      diseases. At the same time for the periodontitis group; the purpose of this study is to
      analyze the correlation of these proteins with clinical parameters at the first and third
      months after the nonsurgical periodontal treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In our study, gingival crevicular fluid samples will be taken along with the measurement of
      all oral clinical parameters from sixty systemically healthy volunteers (20 periodontally
      healthy, 20 gingivitis, and 20 periodontitis). Gingival crevicular fluid samples will be
      taken again after the nonsurgical periodontal treatment for the periodontitis group in the
      first and third months. Lipocalin-2 and Semaphorin 3A levels will be determined by an
      enzyme-linked immunosorbent assay test (ELISA). Subsequent statistical analyses will be used
      to interpret protein levels among different groups and peridontitis group after the
      nonsurgical periodontal treatment.

      Possible significant differences may illuminate the future work with Lipocalin-2 and
      Semaphorin 3A. Also, these glycoproteins may help to develop different diagnostic methods or
      treatment strategies for future periodontal treatments.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The level of Lipocalin-2</measure>
    <time_frame>18 months</time_frame>
    <description>Investigating the concentrations of Lipocalin-2 level in gingival crevicular fluid in subjects with different periodontal diseases.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The level of Semaphorin 3A</measure>
    <time_frame>18 months</time_frame>
    <description>Investigating the concentrations of Semaphorin 3A leves in gingival crevicular fluid in subjects with different periodontal diseases.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effects of non-surgical periodontal treatment on the levels of Lipocalin-2 and Semaphorin3A</measure>
    <time_frame>18 months</time_frame>
    <description>Analyzing the correlation of Lipocalin-2 and Semaphorin3A with clinical parameters at the first and third months after the nonsurgical periodontal treatment</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gingivitis</condition>
  <condition>Periodontitis</condition>
  <condition>Periodontal Diseases</condition>
  <arm_group>
    <arm_group_label>Periodontally Healthy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>20 participants with bleeding on probing less than 10%, probing depths less than 4mm, and no clinical attachment loss which was measured by six sites per tooth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gingivitis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>20 participants with bleeding on probing greater than 10%, probing depths less than 4mm, and no clinical attachment loss which was measured by six sites per tooth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>20 participants with bleeding on probing greater than or equal to 30%, probing depths greater than or equal to 5mm at least non-adjacent two teeth in each quadrant of the dentition, and clinical attachment loss greater than or equal to 4mm which was measured by six sites per tooth, and radiographic bone loss on the coronal third of root or severe (vertical/ horizontal) bone loss.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-surgical Periodontal Treatment</intervention_name>
    <description>Non-surgical periodontal treatment includes scaling and root planning by using curettes and ultrasonic devices only in the periodontitis group.</description>
    <arm_group_label>Periodontitis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being systemically healthy

          -  Having at least 20 teeth in the dentition, excluding third molars

          -  Not using alcohol nor smoking

          -  Not using medications

          -  Not taking any antibiotics, anti-inflammatory, nor systemic corticosteroid drugs in
             the last six months

          -  Not being in the lactation period nor pregnancy

        Exclusion Criteria:

          -  Having any oral or systemic diseases

          -  Using alcohol or smoking

          -  Using medications

          -  Taking any antibiotics, anti-inflammatory, or systemic corticosteroid drugs in the
             last six months

          -  Being in the lactation period or pregnancy

          -  Being treated with periodontal treatment in the last six months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Merve Ceylan, RA</last_name>
    <phone>+905302925543</phone>
    <email>merveceylan93@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Izmir Katip Celebi University, Faculty of Dentistry</name>
      <address>
        <city>Izmir</city>
        <state>Cigli</state>
        <zip>35640</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faculty of Dentistry</last_name>
      <phone>+902323254040</phone>
      <email>dis@ikcu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Merve Ceylan, RA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Izmir Katip Celebi University</investigator_affiliation>
    <investigator_full_name>Merve Ceylan</investigator_full_name>
    <investigator_title>Research Assistant</investigator_title>
  </responsible_party>
  <keyword>Periodontal Disease, Non-surgical Periodontal Treatment, GCF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

